JP2025503607A - セルピンペプチドおよびその使用方法 - Google Patents
セルピンペプチドおよびその使用方法 Download PDFInfo
- Publication number
- JP2025503607A JP2025503607A JP2024540848A JP2024540848A JP2025503607A JP 2025503607 A JP2025503607 A JP 2025503607A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2025503607 A JP2025503607 A JP 2025503607A
- Authority
- JP
- Japan
- Prior art keywords
- serpin
- peptide
- disease
- condition
- serpin peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263266444P | 2022-01-05 | 2022-01-05 | |
| US63/266,444 | 2022-01-05 | ||
| PCT/US2022/082669 WO2023133078A2 (en) | 2022-01-05 | 2022-12-30 | Serpin peptides and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503607A true JP2025503607A (ja) | 2025-02-04 |
| JP2025503607A5 JP2025503607A5 (https=) | 2025-06-02 |
Family
ID=87074167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540848A Pending JP2025503607A (ja) | 2022-01-05 | 2022-12-30 | セルピンペプチドおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20250161419A1 (https=) |
| EP (1) | EP4460322A4 (https=) |
| JP (1) | JP2025503607A (https=) |
| CN (1) | CN118804758A (https=) |
| AU (1) | AU2022431253A1 (https=) |
| CA (1) | CA3247129A1 (https=) |
| IL (1) | IL314135A (https=) |
| WO (1) | WO2023133078A2 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017040287A1 (en) * | 2015-08-28 | 2017-03-09 | Serpin Pharma, Llc | Methods for treatment of diseases |
| WO2017123401A1 (en) * | 2016-01-13 | 2017-07-20 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| EP3773727A4 (en) * | 2018-04-09 | 2022-05-04 | Yale University | BIFUNCTIONAL SMALL MOLECULES TO TARGETING THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS |
| KR20220099963A (ko) * | 2019-10-10 | 2022-07-14 | 예일 유니버시티 | 세포 수용체를 통한 분자 분해제로서의 조작된 항체 |
| US20210162029A1 (en) * | 2019-11-04 | 2021-06-03 | Azitra Inc | Compositions and methods for treatment or prevention of skin diseases and disorders with lekti |
| EP4003391A4 (en) * | 2020-07-06 | 2023-02-22 | Serpin Pharma, LLC | PEPTIDES AND METHODS OF USE THEREOF |
| AU2022222778A1 (en) * | 2021-02-22 | 2023-08-31 | Yale University | Targeted bifunctional degraders and methods using same |
-
2022
- 2022-12-30 IL IL314135A patent/IL314135A/en unknown
- 2022-12-30 JP JP2024540848A patent/JP2025503607A/ja active Pending
- 2022-12-30 CA CA3247129A patent/CA3247129A1/en active Pending
- 2022-12-30 EP EP22919262.0A patent/EP4460322A4/en active Pending
- 2022-12-30 US US18/726,945 patent/US20250161419A1/en active Pending
- 2022-12-30 AU AU2022431253A patent/AU2022431253A1/en active Pending
- 2022-12-30 WO PCT/US2022/082669 patent/WO2023133078A2/en not_active Ceased
- 2022-12-30 CN CN202280092284.4A patent/CN118804758A/zh active Pending
-
2023
- 2023-07-13 US US18/148,942 patent/US20230406906A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230406906A1 (en) | 2023-12-21 |
| AU2022431253A1 (en) | 2024-07-25 |
| WO2023133078A2 (en) | 2023-07-13 |
| CA3247129A1 (en) | 2023-07-13 |
| EP4460322A2 (en) | 2024-11-13 |
| US20250161419A1 (en) | 2025-05-22 |
| IL314135A (en) | 2024-09-01 |
| CN118804758A (zh) | 2024-10-18 |
| EP4460322A4 (en) | 2026-02-25 |
| WO2023133078A3 (en) | 2023-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8158589B2 (en) | Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) | |
| EP3058074B1 (en) | Oral delivery of angiotensin converting enzyme 2 (ace2) or angiotensin-(1-7) bioencapsulated in plant cells | |
| US8734775B2 (en) | Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments | |
| EP2555789A1 (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| US20240261364A1 (en) | Peptides and methods of using the same | |
| CN111184856B (zh) | 小分子多肽tp-7在制备治疗慢性肾脏病药物中的用途 | |
| JP5691049B2 (ja) | 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途 | |
| JP5750766B2 (ja) | 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤 | |
| US20190216901A1 (en) | Acth prophylactic treatment of renal disorders | |
| AU2016317574A1 (en) | Compositions and methods for the treatment of neurodamage | |
| JP2025503607A (ja) | セルピンペプチドおよびその使用方法 | |
| HK40118659A (zh) | Serpin肽及其使用方法 | |
| CN102212111B (zh) | 小分子多肽和小分子多肽脂质体及其运用 | |
| KR20230117342A (ko) | 펩타이드 제제 및 이의 안과적 용도 | |
| CN115279402A (zh) | 对ve-ptp磷酸酶的抑制保护肾免于缺血-再灌注损伤 | |
| RU2855148C2 (ru) | Средство с рекомбинатным аналогом пептида морской анемоны для лечения аллергического дерматита и псориаза | |
| US20250353898A1 (en) | Serpin peptide derivatives and methods of using the same | |
| US20250066452A1 (en) | Synthetic amphipathic helical peptides and treatment methods using synthetic amphipathic helical peptides | |
| HK40121727A (zh) | Serpin肽衍生物及其使用方法 | |
| KR20180120341A (ko) | 폐 섬유증의 예방 또는 치료용 약학적 조성물 | |
| KR102115557B1 (ko) | 폐 섬유증의 예방 또는 치료용 약학적 조성물 | |
| EP4000627A1 (en) | Treatment of abdominal aortic aneurysm after its clinical manifestation | |
| WO2024145334A2 (en) | Hoxa3 treatment methods for accelerating wound healing in aged non-diabetic mice | |
| KR20230034167A (ko) | Kai1 폴리펩타이드를 포함하는 간 섬유화 억제용 약학 조성물 및 이의 용도 | |
| Heskamp | Role of CXCL12 and CXCR4 in axonal regeneration of mature retinal ganglion cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241004 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250523 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250523 |